Aesthetic portal - professionally about beauty
Language:
Xeomin – A Botulinum Toxin Product Without Complexing Proteins

Xeomin – A Botulinum Toxin Product Without Complexing Proteins

Article under preparation

This article is currently available only in Russian. You can switch the language in the top language bar to view the Russian version, or check back soon — the English translation will be available shortly.

Similar posts:

  • Why Does Botox Not Last as Long Anymore?
    Why Does Botox Not Last as Long Anymore?

    Many people have noticed that lately the effect of Botox has become shorter. Previously, the results lasted about six months, but now only around three. Is it tolerance? Are cosmetologists diluting the product more? Has the composition of the drug changed?

  • Which is better: Botox or Dysport?
    Which is better: Botox or Dysport?

    Modern aesthetic medicine offers two identical products for eliminating expression lines — Botox and Dysport. But how do they differ? And which one should you choose?

  • AbbVie Submits Biologics License Application to U.S. FDA of a new botulinum toxin type E
    AbbVie Submits Biologics License Application to U.S. FDA of a new botulinum toxin type E

    AbbVie has submitted an application to the FDA for the approval of TrenibotE — the first-in-class botulinum toxin type E. The product demonstrates a record-fast onset of action (8 hours) and a short duration of effect (2-3 weeks), which may change the approach to initial injections in patients who have previously avoided neurotoxins.